Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2024(Status and Outlook)
Report Overview
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The global Infectious Diseases Molecular Diagnostics Kit market size was estimated at USD 31410 million in 2023 and is projected to reach USD 52110.73 million by 2030, exhibiting a CAGR of 7.50% during the forecast period.
North America Infectious Diseases Molecular Diagnostics Kit market size was USD 8184.55 million in 2023, at a CAGR of 6.43% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Infectious Diseases Molecular Diagnostics Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Diseases Molecular Diagnostics Kit Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Diseases Molecular Diagnostics Kit market in any manner.
Global Infectious Diseases Molecular Diagnostics Kit Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Market Segmentation (by Type)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market Segmentation (by Application)
Hospital
Third-party Testing Agency
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Diseases Molecular Diagnostics Kit Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The global Infectious Diseases Molecular Diagnostics Kit market size was estimated at USD 31410 million in 2023 and is projected to reach USD 52110.73 million by 2030, exhibiting a CAGR of 7.50% during the forecast period.
North America Infectious Diseases Molecular Diagnostics Kit market size was USD 8184.55 million in 2023, at a CAGR of 6.43% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Infectious Diseases Molecular Diagnostics Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Diseases Molecular Diagnostics Kit Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Diseases Molecular Diagnostics Kit market in any manner.
Global Infectious Diseases Molecular Diagnostics Kit Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Market Segmentation (by Type)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market Segmentation (by Application)
Hospital
Third-party Testing Agency
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Diseases Molecular Diagnostics Kit Market
- Overview of the regional outlook of the Infectious Diseases Molecular Diagnostics Kit Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Diseases Molecular Diagnostics Kit Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Diseases Molecular Diagnostics Kit
1.2 Key Market Segments
1.2.1 Infectious Diseases Molecular Diagnostics Kit Segment by Type
1.2.2 Infectious Diseases Molecular Diagnostics Kit Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Diseases Molecular Diagnostics Kit Sales by Manufacturers (2019-2024)
3.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Diseases Molecular Diagnostics Kit Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Diseases Molecular Diagnostics Kit Sales Sites, Area Served, Product Type
3.6 Infectious Diseases Molecular Diagnostics Kit Market Competitive Situation and Trends
3.6.1 Infectious Diseases Molecular Diagnostics Kit Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Diseases Molecular Diagnostics Kit Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT INDUSTRY CHAIN ANALYSIS
4.1 Infectious Diseases Molecular Diagnostics Kit Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Type (2019-2024)
6.3 Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Diseases Molecular Diagnostics Kit Price by Type (2019-2024)
7 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Diseases Molecular Diagnostics Kit Market Sales by Application (2019-2024)
7.3 Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Diseases Molecular Diagnostics Kit Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SEGMENTATION BY REGION
8.1 Global Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.1.1 Global Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.1.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Diseases Molecular Diagnostics Kit Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Diseases Molecular Diagnostics Kit Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Diseases Molecular Diagnostics Kit Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Infectious Diseases Molecular Diagnostics Kit Basic Information
9.1.2 Roche Infectious Diseases Molecular Diagnostics Kit Product Overview
9.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Qiagen
9.2.1 Qiagen Infectious Diseases Molecular Diagnostics Kit Basic Information
9.2.2 Qiagen Infectious Diseases Molecular Diagnostics Kit Product Overview
9.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.2.4 Qiagen Business Overview
9.2.5 Qiagen Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
9.2.6 Qiagen Recent Developments
9.3 Illumina
9.3.1 Illumina Infectious Diseases Molecular Diagnostics Kit Basic Information
9.3.2 Illumina Infectious Diseases Molecular Diagnostics Kit Product Overview
9.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.3.4 Illumina Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Abbott
9.4.1 Abbott Infectious Diseases Molecular Diagnostics Kit Basic Information
9.4.2 Abbott Infectious Diseases Molecular Diagnostics Kit Product Overview
9.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Hologic
9.5.1 Hologic Infectious Diseases Molecular Diagnostics Kit Basic Information
9.5.2 Hologic Infectious Diseases Molecular Diagnostics Kit Product Overview
9.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.5.4 Hologic Business Overview
9.5.5 Hologic Recent Developments
9.6 BioMerieux
9.6.1 BioMerieux Infectious Diseases Molecular Diagnostics Kit Basic Information
9.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Overview
9.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.6.4 BioMerieux Business Overview
9.6.5 BioMerieux Recent Developments
9.7 Danaher (Cepheid)
9.7.1 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Basic Information
9.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Overview
9.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.7.4 Danaher (Cepheid) Business Overview
9.7.5 Danaher (Cepheid) Recent Developments
9.8 Myriad Genetics
9.8.1 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Basic Information
9.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Overview
9.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.8.4 Myriad Genetics Business Overview
9.8.5 Myriad Genetics Recent Developments
9.9 DAAN Gene
9.9.1 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Basic Information
9.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Overview
9.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.9.4 DAAN Gene Business Overview
9.9.5 DAAN Gene Recent Developments
9.10 Agilent
9.10.1 Agilent Infectious Diseases Molecular Diagnostics Kit Basic Information
9.10.2 Agilent Infectious Diseases Molecular Diagnostics Kit Product Overview
9.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.10.4 Agilent Business Overview
9.10.5 Agilent Recent Developments
9.11 Genomic Health
9.11.1 Genomic Health Infectious Diseases Molecular Diagnostics Kit Basic Information
9.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Overview
9.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.11.4 Genomic Health Business Overview
9.11.5 Genomic Health Recent Developments
9.12 BD
9.12.1 BD Infectious Diseases Molecular Diagnostics Kit Basic Information
9.12.2 BD Infectious Diseases Molecular Diagnostics Kit Product Overview
9.12.3 BD Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.12.4 BD Business Overview
9.12.5 BD Recent Developments
9.13 Foundation Medicine
9.13.1 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Basic Information
9.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Overview
9.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.13.4 Foundation Medicine Business Overview
9.13.5 Foundation Medicine Recent Developments
10 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET FORECAST BY REGION
10.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast
10.2 Global Infectious Diseases Molecular Diagnostics Kit Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Region
10.2.4 South America Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Diseases Molecular Diagnostics Kit by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Diseases Molecular Diagnostics Kit Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Diseases Molecular Diagnostics Kit by Type (2025-2030)
11.1.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Diseases Molecular Diagnostics Kit by Type (2025-2030)
11.2 Global Infectious Diseases Molecular Diagnostics Kit Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) Forecast by Application
11.2.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Diseases Molecular Diagnostics Kit
1.2 Key Market Segments
1.2.1 Infectious Diseases Molecular Diagnostics Kit Segment by Type
1.2.2 Infectious Diseases Molecular Diagnostics Kit Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Diseases Molecular Diagnostics Kit Sales by Manufacturers (2019-2024)
3.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Diseases Molecular Diagnostics Kit Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Diseases Molecular Diagnostics Kit Sales Sites, Area Served, Product Type
3.6 Infectious Diseases Molecular Diagnostics Kit Market Competitive Situation and Trends
3.6.1 Infectious Diseases Molecular Diagnostics Kit Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Diseases Molecular Diagnostics Kit Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT INDUSTRY CHAIN ANALYSIS
4.1 Infectious Diseases Molecular Diagnostics Kit Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Type (2019-2024)
6.3 Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Diseases Molecular Diagnostics Kit Price by Type (2019-2024)
7 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Diseases Molecular Diagnostics Kit Market Sales by Application (2019-2024)
7.3 Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Diseases Molecular Diagnostics Kit Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SEGMENTATION BY REGION
8.1 Global Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.1.1 Global Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.1.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Diseases Molecular Diagnostics Kit Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Diseases Molecular Diagnostics Kit Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Diseases Molecular Diagnostics Kit Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Infectious Diseases Molecular Diagnostics Kit Basic Information
9.1.2 Roche Infectious Diseases Molecular Diagnostics Kit Product Overview
9.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Qiagen
9.2.1 Qiagen Infectious Diseases Molecular Diagnostics Kit Basic Information
9.2.2 Qiagen Infectious Diseases Molecular Diagnostics Kit Product Overview
9.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.2.4 Qiagen Business Overview
9.2.5 Qiagen Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
9.2.6 Qiagen Recent Developments
9.3 Illumina
9.3.1 Illumina Infectious Diseases Molecular Diagnostics Kit Basic Information
9.3.2 Illumina Infectious Diseases Molecular Diagnostics Kit Product Overview
9.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.3.4 Illumina Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Abbott
9.4.1 Abbott Infectious Diseases Molecular Diagnostics Kit Basic Information
9.4.2 Abbott Infectious Diseases Molecular Diagnostics Kit Product Overview
9.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Hologic
9.5.1 Hologic Infectious Diseases Molecular Diagnostics Kit Basic Information
9.5.2 Hologic Infectious Diseases Molecular Diagnostics Kit Product Overview
9.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.5.4 Hologic Business Overview
9.5.5 Hologic Recent Developments
9.6 BioMerieux
9.6.1 BioMerieux Infectious Diseases Molecular Diagnostics Kit Basic Information
9.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Overview
9.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.6.4 BioMerieux Business Overview
9.6.5 BioMerieux Recent Developments
9.7 Danaher (Cepheid)
9.7.1 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Basic Information
9.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Overview
9.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.7.4 Danaher (Cepheid) Business Overview
9.7.5 Danaher (Cepheid) Recent Developments
9.8 Myriad Genetics
9.8.1 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Basic Information
9.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Overview
9.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.8.4 Myriad Genetics Business Overview
9.8.5 Myriad Genetics Recent Developments
9.9 DAAN Gene
9.9.1 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Basic Information
9.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Overview
9.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.9.4 DAAN Gene Business Overview
9.9.5 DAAN Gene Recent Developments
9.10 Agilent
9.10.1 Agilent Infectious Diseases Molecular Diagnostics Kit Basic Information
9.10.2 Agilent Infectious Diseases Molecular Diagnostics Kit Product Overview
9.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.10.4 Agilent Business Overview
9.10.5 Agilent Recent Developments
9.11 Genomic Health
9.11.1 Genomic Health Infectious Diseases Molecular Diagnostics Kit Basic Information
9.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Overview
9.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.11.4 Genomic Health Business Overview
9.11.5 Genomic Health Recent Developments
9.12 BD
9.12.1 BD Infectious Diseases Molecular Diagnostics Kit Basic Information
9.12.2 BD Infectious Diseases Molecular Diagnostics Kit Product Overview
9.12.3 BD Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.12.4 BD Business Overview
9.12.5 BD Recent Developments
9.13 Foundation Medicine
9.13.1 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Basic Information
9.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Overview
9.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Market Performance
9.13.4 Foundation Medicine Business Overview
9.13.5 Foundation Medicine Recent Developments
10 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET FORECAST BY REGION
10.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast
10.2 Global Infectious Diseases Molecular Diagnostics Kit Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Region
10.2.4 South America Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Diseases Molecular Diagnostics Kit by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Diseases Molecular Diagnostics Kit Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Diseases Molecular Diagnostics Kit by Type (2025-2030)
11.1.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Diseases Molecular Diagnostics Kit by Type (2025-2030)
11.2 Global Infectious Diseases Molecular Diagnostics Kit Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) Forecast by Application
11.2.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Diseases Molecular Diagnostics Kit Market Size Comparison by Region (M USD)
Table 5. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Diseases Molecular Diagnostics Kit Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Diseases Molecular Diagnostics Kit Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2022)
Table 10. Global Market Infectious Diseases Molecular Diagnostics Kit Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Diseases Molecular Diagnostics Kit Sales Sites and Area Served
Table 12. Manufacturers Infectious Diseases Molecular Diagnostics Kit Product Type
Table 13. Global Infectious Diseases Molecular Diagnostics Kit Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Diseases Molecular Diagnostics Kit
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Diseases Molecular Diagnostics Kit Market Challenges
Table 22. Global Infectious Diseases Molecular Diagnostics Kit Sales by Type (K Units)
Table 23. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Type (M USD)
Table 24. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) by Type (2019-2024)
Table 25. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Diseases Molecular Diagnostics Kit Market Size Share by Type (2019-2024)
Table 28. Global Infectious Diseases Molecular Diagnostics Kit Price (USD/Unit) by Type (2019-2024)
Table 29. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) by Application
Table 30. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application
Table 31. Global Infectious Diseases Molecular Diagnostics Kit Sales by Application (2019-2024) & (K Units)
Table 32. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Diseases Molecular Diagnostics Kit Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2024)
Table 35. Global Infectious Diseases Molecular Diagnostics Kit Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Diseases Molecular Diagnostics Kit Sales by Region (2019-2024) & (K Units)
Table 37. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Diseases Molecular Diagnostics Kit Sales by Country (2019-2024) & (K Units)
Table 39. Europe Infectious Diseases Molecular Diagnostics Kit Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales by Region (2019-2024) & (K Units)
Table 41. South America Infectious Diseases Molecular Diagnostics Kit Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales by Region (2019-2024) & (K Units)
Table 43. Roche Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 44. Roche Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 45. Roche Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Qiagen Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 50. Qiagen Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 51. Qiagen Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Qiagen Business Overview
Table 53. Qiagen Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
Table 54. Qiagen Recent Developments
Table 55. Illumina Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 56. Illumina Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 57. Illumina Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Illumina Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
Table 59. Illumina Business Overview
Table 60. Illumina Recent Developments
Table 61. Abbott Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 62. Abbott Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 63. Abbott Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Abbott Business Overview
Table 65. Abbott Recent Developments
Table 66. Hologic Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 67. Hologic Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 68. Hologic Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Hologic Business Overview
Table 70. Hologic Recent Developments
Table 71. BioMerieux Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 72. BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 73. BioMerieux Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BioMerieux Business Overview
Table 75. BioMerieux Recent Developments
Table 76. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 77. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 78. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Danaher (Cepheid) Business Overview
Table 80. Danaher (Cepheid) Recent Developments
Table 81. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 82. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 83. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Myriad Genetics Business Overview
Table 85. Myriad Genetics Recent Developments
Table 86. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 87. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 88. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. DAAN Gene Business Overview
Table 90. DAAN Gene Recent Developments
Table 91. Agilent Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 92. Agilent Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 93. Agilent Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Agilent Business Overview
Table 95. Agilent Recent Developments
Table 96. Genomic Health Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 97. Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 98. Genomic Health Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Genomic Health Business Overview
Table 100. Genomic Health Recent Developments
Table 101. BD Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 102. BD Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 103. BD Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. BD Business Overview
Table 105. BD Recent Developments
Table 106. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 107. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 108. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Foundation Medicine Business Overview
Table 110. Foundation Medicine Recent Developments
Table 111. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Infectious Diseases Molecular Diagnostics Kit Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Diseases Molecular Diagnostics Kit Market Size Comparison by Region (M USD)
Table 5. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Diseases Molecular Diagnostics Kit Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Diseases Molecular Diagnostics Kit Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2022)
Table 10. Global Market Infectious Diseases Molecular Diagnostics Kit Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Diseases Molecular Diagnostics Kit Sales Sites and Area Served
Table 12. Manufacturers Infectious Diseases Molecular Diagnostics Kit Product Type
Table 13. Global Infectious Diseases Molecular Diagnostics Kit Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Diseases Molecular Diagnostics Kit
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Diseases Molecular Diagnostics Kit Market Challenges
Table 22. Global Infectious Diseases Molecular Diagnostics Kit Sales by Type (K Units)
Table 23. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Type (M USD)
Table 24. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) by Type (2019-2024)
Table 25. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Diseases Molecular Diagnostics Kit Market Size Share by Type (2019-2024)
Table 28. Global Infectious Diseases Molecular Diagnostics Kit Price (USD/Unit) by Type (2019-2024)
Table 29. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) by Application
Table 30. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application
Table 31. Global Infectious Diseases Molecular Diagnostics Kit Sales by Application (2019-2024) & (K Units)
Table 32. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Diseases Molecular Diagnostics Kit Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2024)
Table 35. Global Infectious Diseases Molecular Diagnostics Kit Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Diseases Molecular Diagnostics Kit Sales by Region (2019-2024) & (K Units)
Table 37. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Diseases Molecular Diagnostics Kit Sales by Country (2019-2024) & (K Units)
Table 39. Europe Infectious Diseases Molecular Diagnostics Kit Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales by Region (2019-2024) & (K Units)
Table 41. South America Infectious Diseases Molecular Diagnostics Kit Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales by Region (2019-2024) & (K Units)
Table 43. Roche Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 44. Roche Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 45. Roche Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Qiagen Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 50. Qiagen Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 51. Qiagen Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Qiagen Business Overview
Table 53. Qiagen Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
Table 54. Qiagen Recent Developments
Table 55. Illumina Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 56. Illumina Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 57. Illumina Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Illumina Infectious Diseases Molecular Diagnostics Kit SWOT Analysis
Table 59. Illumina Business Overview
Table 60. Illumina Recent Developments
Table 61. Abbott Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 62. Abbott Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 63. Abbott Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Abbott Business Overview
Table 65. Abbott Recent Developments
Table 66. Hologic Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 67. Hologic Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 68. Hologic Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Hologic Business Overview
Table 70. Hologic Recent Developments
Table 71. BioMerieux Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 72. BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 73. BioMerieux Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BioMerieux Business Overview
Table 75. BioMerieux Recent Developments
Table 76. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 77. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 78. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Danaher (Cepheid) Business Overview
Table 80. Danaher (Cepheid) Recent Developments
Table 81. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 82. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 83. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Myriad Genetics Business Overview
Table 85. Myriad Genetics Recent Developments
Table 86. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 87. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 88. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. DAAN Gene Business Overview
Table 90. DAAN Gene Recent Developments
Table 91. Agilent Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 92. Agilent Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 93. Agilent Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Agilent Business Overview
Table 95. Agilent Recent Developments
Table 96. Genomic Health Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 97. Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 98. Genomic Health Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Genomic Health Business Overview
Table 100. Genomic Health Recent Developments
Table 101. BD Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 102. BD Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 103. BD Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. BD Business Overview
Table 105. BD Recent Developments
Table 106. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Basic Information
Table 107. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Overview
Table 108. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Foundation Medicine Business Overview
Table 110. Foundation Medicine Recent Developments
Table 111. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Infectious Diseases Molecular Diagnostics Kit Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Diseases Molecular Diagnostics Kit
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD), 2019-2030
Figure 5. Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Diseases Molecular Diagnostics Kit Market Size by Country (M USD)
Figure 11. Infectious Diseases Molecular Diagnostics Kit Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Diseases Molecular Diagnostics Kit Revenue Share by Manufacturers in 2023
Figure 13. Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Diseases Molecular Diagnostics Kit Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Type
Figure 18. Sales Market Share of Infectious Diseases Molecular Diagnostics Kit by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Diseases Molecular Diagnostics Kit by Type in 2023
Figure 20. Market Size Share of Infectious Diseases Molecular Diagnostics Kit by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Diseases Molecular Diagnostics Kit by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application
Figure 24. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Application in 2023
Figure 26. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2024)
Figure 27. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application in 2023
Figure 28. Global Infectious Diseases Molecular Diagnostics Kit Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Infectious Diseases Molecular Diagnostics Kit Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Diseases Molecular Diagnostics Kit Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country in 2023
Figure 37. Germany Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region in 2023
Figure 44. China Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (K Units)
Figure 50. South America Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Diseases Molecular Diagnostics Kit Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Diseases Molecular Diagnostics Kit Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Infectious Diseases Molecular Diagnostics Kit
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD), 2019-2030
Figure 5. Global Infectious Diseases Molecular Diagnostics Kit Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Diseases Molecular Diagnostics Kit Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Diseases Molecular Diagnostics Kit Market Size by Country (M USD)
Figure 11. Infectious Diseases Molecular Diagnostics Kit Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Diseases Molecular Diagnostics Kit Revenue Share by Manufacturers in 2023
Figure 13. Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Diseases Molecular Diagnostics Kit Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Type
Figure 18. Sales Market Share of Infectious Diseases Molecular Diagnostics Kit by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Diseases Molecular Diagnostics Kit by Type in 2023
Figure 20. Market Size Share of Infectious Diseases Molecular Diagnostics Kit by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Diseases Molecular Diagnostics Kit by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application
Figure 24. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Application in 2023
Figure 26. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2024)
Figure 27. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application in 2023
Figure 28. Global Infectious Diseases Molecular Diagnostics Kit Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Infectious Diseases Molecular Diagnostics Kit Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Diseases Molecular Diagnostics Kit Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country in 2023
Figure 37. Germany Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region in 2023
Figure 44. China Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (K Units)
Figure 50. South America Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Infectious Diseases Molecular Diagnostics Kit Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Diseases Molecular Diagnostics Kit Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Diseases Molecular Diagnostics Kit Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Diseases Molecular Diagnostics Kit Market Share Forecast by Application (2025-2030)
